It is a pharma private limited company based in Burdwan - I, West Bengal, India, established in 2022.
2022 | Burdwan - I, West Bengal, India | ActiveColumbine Pharmaceuticals Private Limited, a active private limited company, was established on 14 July 2022 in Burdwan - I, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24290WB2022PTC255596. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Ranjit Chakrabarty (Director), Ananta Biswas (Director), Atanu Chakraborty (Director). Past directors included Lakshmi Narayan Ghosh, Tarak Nath Ghosh. It holds ₹0.30 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Holding No-134, Mehedibagan, G.T Road, Po-Burdwan, Burdwan - I, West Bengal, 713101.
U24290WB2022PTC255596
255596
14 July 2022
₹1.50 M
₹0.40 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Columbine Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranjit Chakrabarty | Director | 15 Sep 2023 | Current |
| Ananta Biswas | Director | 15 Sep 2023 | Current |
| Atanu Chakraborty | Director | 14 Jul 2022 | Current |
| Debashis Ghosh | Director | 14 Jul 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Aug 2023 | Past |
| Pramod Abcsdd | Director | 06 Feb 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Columbine Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Columbine Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2024 | Canara Bank | ₹0.30 M | Open |
Explore comprehensive loan charge details -
Columbine Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Columbine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Columbine Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Columbine Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Columbine Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.
Progress on A charge with Canara Bank amounted to Rs. 0.30 M with Charge ID 100864468 was registered on 10 Jan 2024. was documented.
The activity Ranjit Chakrabarty was appointed as a Director was appointed as a Director on 15 Sep 2023 & has been associated with this company since 2 years 4 months . was completed.
The activity Ananta Biswas was appointed as a Director was appointed as a Director on 15 Sep 2023 & has been associated with this company since 2 years 4 months . was completed.
Atanu Chakraborty was appointed as a Director was appointed as a Director on 14 Jul 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
The CIN of Columbine Pharmaceuticals Private Limited is U24290WB2022PTC255596.
Columbine Pharmaceuticals Private Limited is headquartered at Holding No-134, Mehedibagan, G.T Road, Po-Burdwan, Burdwan - I, West Bengal, 713101.
Columbine Pharmaceuticals Private Limited was incorporated on 14 July 2022.
The current directors of Columbine Pharmaceuticals Private Limited are
The primary industry of Columbine Pharmaceuticals Private Limited is Pharma.
Columbine Pharmaceuticals Private Limited is unlisted.
The authorized capital of Columbine Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.40 M.
The compliance status of Columbine Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX